Home › Funds › Sycale Advisors (NY) LLC › GENI

Sycale Advisors (NY) LLC position in GENI

GENIUS SPORTS LIMITED · Consumer Discretionary

Sycale Advisors (NY) LLC reported holding 1,734,960 shares of GENI (GENIUS SPORTS LIMITED) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 2.80% of its reported portfolio and ranking #16 among its reported holdings. Sycale Advisors (NY) LLC has disclosed GENI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)1.73M sh
Reported value held$9.94M
Portfolio Weight2.80%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sycale Advisors (NY) LLC's GENI position evolved

Sycale Advisors (NY) LLC first disclosed a stake in GENI in Q4 2024 at 1,400,342 shares (US$12.1M). The position peaked in Q4 2025 at 1,876,046 shares, worth US$20.7M. Across 8 filings, Sycale Advisors (NY) LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,734,960 shares valued at US$9.9M — a reduction of -201,100 shares quarter over quarter.. Notable position changes include a 43% trim in Q1 2025 (shares rose 4% over the following quarter), a 93% increase in Q2 2025 (shares rose 19% over the following quarter), a 43% increase in Q4 2025 (shares fell 60% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.40M $12.11M New
Q1 2025 803.24K $8.04M Reduce
Q2 2025 1.55M $16.10M Add
Q3 2025 1.31M $16.21M Reduce
Q4 2025 1.88M $20.67M Add
Q1 2026 2.04M $9.02M Add
Q2 2026 1.94M $11.73M Reduce
Q3 2026 1.73M $9.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GENI and 13F data

GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 22 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GENI

All GENI fund holders →

FAQ

How long has Sycale Advisors (NY) LLC held GENI?

Sycale Advisors (NY) LLC has disclosed GENI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Sycale Advisors (NY) LLC's current position in GENI?

As of Q3 2026, Sycale Advisors (NY) LLC holds 1.73M shares of GENI (GENIUS SPORTS LIMITED), valued at $9.94M, representing 2.80% of its reported portfolio and ranking #16.

Has Sycale Advisors (NY) LLC been buying or selling GENI?

In the latest 13F filing (Q3 2026), Sycale Advisors (NY) LLC reduced its position in GENI. The position peaked in Q4 2025 at 1.88M shares.

Which other funds hold GENI?

Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.